SCHEMBL17618094

SCHEMBL17618094

c1ccc(-c2cc(-c3ccc4c(c3)c3cnccc3n4-c3ccccc3)nc(-c3cccc(-c4c5ccccc5c(-c5ccccc5)c5ccccc45)n3)n2)cc1

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.32
▸ KMT2A Q03164 4/20 0.32
▸ MEN1 O00255 3/20 0.32
▸ KDM4E B2RXH2 3/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ LMNA P02545 2/20 0.32
▸ HPGD P15428 2/20 0.32
▸ GLA P06280 1/20 0.32
▸ CYP19A1 P11511 1/20 0.32
▸ DHODH Q02127 1/20 0.31
▸ ALOX5 P09917 1/20 0.31
▸ HSP90AA1 P07900 1/20 0.31
▸ TNF P01375 1/20 0.31
▸ ATM Q13315 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ PTGER4 P35408 1/20 0.30
▸ PDE4B Q07343 1/20 0.30
▸ MAPK10 P53779 1/20 0.30
▸ NPY5R Q15761 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12169047 0.92 KMT2A (0.33) MAPTKMT2AMEN1KDM4ECYP19A1
SCHEMBL17369025 0.91 KMT2A (0.38) MAPTKMT2AMEN1KDM4EALDH1A1
SCHEMBL17618100 0.91 KMT2A (0.38) MAPTKMT2AMEN1KDM4EALDH1A1
SCHEMBL17618123 0.90 KMT2A (0.39) MAPTKMT2AMEN1KDM4EALDH1A1
SCHEMBL17618135 0.90 KMT2A (0.36) MAPTKMT2AMEN1KDM4EALDH1A1
SCHEMBL17618126 0.89 KMT2A (0.35) MAPTKMT2AMEN1KDM4EALDH1A1
SCHEMBL17618098 0.89 KMT2A (0.35) MAPTKMT2AMEN1KDM4EALDH1A1
SCHEMBL17618133 0.89 KMT2A (0.35) MAPTKMT2AMEN1KDM4EALDH1A1
SCHEMBL15432052 0.89 ATM (0.34) MAPTKMT2AMEN1KDM4ECYP19A1
SCHEMBL17618128 0.88 KMT2A (0.36) MAPTKMT2AMEN1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160087215-A1 NOVEL PYRIMIDINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES HODOGAYA CHEMICAL CO., LTD. (JP) 2016-03-24 — — US disclosed
US-20160087215-A1 NOVEL PYRIMIDINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES HODOGAYA CHEMICAL CO., LTD. (JP) 2016-03-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160087215-A1 NOVEL PYRIMIDINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES SLC29A1, SLC29A2, DHX29 MAPT 3660/4885KMT2A 2216/4885MEN1 2846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback